Yoshitaka Imura

Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High‐Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis

Hideaki Tsuji, Ran Nakashima, Yuji Hosono et al. · Arthritis & Rheumatology · 2019 · 344 citations · Full text

The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody

Ran Nakashima, Yoshitaka Imura, Shio Kobayashi et al. · Lara D. Veeken · 2009 · 329 citations

Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies

Hajime Yoshifuji, Takao Fujii, Shio Kobayashi et al. · Autoimmunity · 2006 · 206 citations

Asthma, Rheumatology, Autoimmune Disease +14

Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease

Hironao Hozumi, Tomoyuki Fujisawa, Ran Nakashima et al. · Respiratory Medicine · 2016 · 181 citations · Full text

Rheumatology, Comprehensive Assessment, Autoimmune Disease +8

Comprehensive microRNA Analysis Identifies miR-24 and miR-125a-5p as Plasma Biomarkers for Rheumatoid Arthritis

Koichi Murata, Moritoshi Furu, Hiroyuki Yoshitomi et al. · PLoS ONE · 2013 · 179 citations · Full text

Immunology, Pathology, Psoriatic Arthritis +19